Kopran Ltd.
BSE: 524280 | Sector: Health care |
NSE: KOPRAN | ISIN Code: INE082A01010 |
BSE 14:34 | 01 Feb | 126.25 |
-3.95 (-3.03%) |
OPEN
130.90 |
HIGH
138.00 |
LOW
125.75 |
NSE 14:24 | 01 Feb | 126.25 |
-3.40 (-2.62%) |
OPEN
130.95 |
HIGH
137.90 |
LOW
125.30 |
OPEN | 130.90 |
PREVIOUS CLOSE | 130.20 |
VOLUME | 18925 |
52-Week high | 327.35 |
52-Week low | 125.75 |
P/E | 21.15 |
Mkt Cap.(Rs cr) | 609 |
Buy Price | 126.10 |
Buy Qty | 1.00 |
Sell Price | 126.30 |
Sell Qty | 1.00 |
Kopran Ltd. (KOPRAN) - Competition
COMPANY | Last Price | Market Cap. (Rs. cr.) |
Sales Turnover | Net Profit | Total Assets |
Sun Pharma.Inds. | 1,009.45 | 242,197.33 | 15,585.98 | -99.99 | 30,678.37 |
Divi's Lab. | 3,324.05 | 88,236.91 | 8,879.82 | 2,948.54 | 11,718.06 |
Cipla | 1,025.90 | 82,805.51 | 13,091.79 | 2,957.93 | 22,671.86 |
Dr Reddy's Labs | 4,340.00 | 72,269.68 | 14,405.20 | 1,623.20 | 20,636.20 |
Apollo Hospitals | 4,264.65 | 61,317.14 | 6,098.30 | 665.20 | 8,868.60 |
Torrent Pharma. | 1,522.90 | 51,541.03 | 6,742.32 | 991.45 | 9,910.76 |
Zydus Lifesci. | 435.70 | 44,101.55 | 7,981.90 | 857.90 | 16,096.50 |
Abbott India | 20,709.00 | 44,006.62 | 4,919.27 | 798.70 | 3,063.88 |
Max Healthcare | 436.40 | 42,367.46 | 1,800.06 | 331.13 | 6,780.23 |
Alkem Lab | 3,033.20 | 36,261.91 | 8,829.81 | 1,541.25 | 11,301.35 |
Lupin | 736.90 | 33,521.58 | 11,771.67 | -188.70 | 19,439.28 |
Biocon | 239.00 | 28,694.34 | 1,738.20 | 86.10 | 8,279.00 |
Aurobindo Pharma | 412.50 | 24,168.38 | 11,287.14 | 1,454.71 | 19,017.26 |
Syngene Intl. | 571.75 | 22,951.76 | 2,601.40 | 393.80 | 4,609.20 |
Ipca Labs. | 853.55 | 21,654.56 | 5,399.36 | 870.94 | 6,342.72 |
Glaxosmi. Pharma | 1,251.50 | 21,201.66 | 3,217.51 | 1,690.53 | 2,948.24 |
Fortis Health. | 279.80 | 21,123.78 | 895.63 | -13.25 | 10,080.65 |
Gland Pharma | 1,270.05 | 20,917.72 | 4,400.71 | 1,212.16 | 7,164.70 |
Laurus Labs | 333.50 | 17,963.98 | 4,707.04 | 750.09 | 5,178.13 |
Pfizer | 3,834.75 | 17,543.98 | 2,610.99 | 612.56 | 3,086.87 |
Quick Links for Kopran:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices